AI Science Tracker
EN

Shanghai Tenth People's Hospital

2 discoveries from 2022 to 2024

Discoveries

Correlation between Neutrophil-to-Lymphocyte Ratio and Diabetic Neuropathy in Chinese Adults with Type 2 Diabetes Mellitus Using Machine Learning Methods.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: The primary full text's Methods and Results support the assigned case-specific AI-enabled result: Machine learning linked neutrophil-to-lymphocyte ratio to diabetic neuropathy in adults with type-2 diabetes.

Technology: Machine-learning association analysis

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Analyzes clinical data to identify the relationship between neutrophil-to-lymphocyte ratio and diabetic neuropathy in adults with type 2 diabetes.
Limitation / still unknown
The reported evaluation does not establish prospective benefit or performance beyond the studied setting.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11306726/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Identification of Six Diagnostic Biomarkers for Chronic Lymphocytic Leukemia Based on Machine Learning Algorithms

Source check: Source checked. Not independent scientific confirmation.

Finding: The primary full text's Methods and Results support the assigned case-specific AI-enabled result: Machine-learning algorithms identified six chronic-lymphocytic-leukemia biomarkers with training and validation-cohort performance.

Technology: Machine-learning feature-selection models for leukemia biomarkers

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Selects six chronic-lymphocytic-leukemia diagnostic biomarkers and evaluates classification in training and validation cohorts.
Test and result
The full text describes its data/cohort, comparison and evaluation appropriate to the represented result; the claim is limited to this study.
Limitation / still unknown
The reported evaluation does not establish prospective benefit or performance beyond the studied setting.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9715328/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.